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Sox9 encodes an essential transcriptional regulator
of chondrocyte specification and differentiation.
When Sox9 nuclear activity was compared with
markers of chromatin organization and transcrip-
tional activity in primary chondrocytes, we identified
two distinct categories of target association. Class I
sites cluster around the transcriptional start sites of
highly expressed genes with no chondrocyte-spe-
cific signature. Here, Sox9 association reflects pro-
tein-protein association with basal transcriptional
components. Class II sites highlight evolutionarily
conserved active enhancers that direct chondro-
cyte-related gene activity through the direct binding
of Sox9 dimer complexes to DNA. Sox9 binds
through sites with sub-optimal binding affinity; the
number and grouping of enhancers into super-
enhancer clusters likely determines the levels of
target gene expression. Interestingly, comparison
of Sox9 action in distinct chondrocyte lineages
points to similar regulatory strategies. In addition
to providing insights into Sox family action, our
comprehensive identification of the chondrocyte
regulatory genome will facilitate the study of skeletal
development and human disease.INTRODUCTION
The mammalian skeleton is synthesized by cartilage-secreting
chondrocytes and bone-forming osteoblasts. Different skeletal
structures arise from distinct cell lineages: neural crest cells
form much of the cranial vault and face; paraxial mesoderm de-
rivatives generate additional head structures, vertebrae, and
ribs, whereas lateral plate mesoderm derivatives generate the
sternum and limb skeleton (Olsen et al., 2000). Direct intra-
membranous ossification and cartilage-templated endochon-
dral ossification represent alternate modes of bone formationfor specific skeletal structures (Helms and Schneider, 2003; Kro-
nenberg, 2003). In endochondral ossification, mesenchymal
cells initially differentiate into mitotic chondrocytes that deposit
extracellular matrix to form cartilage molds. Mitotic chon-
drocytes transition to postmitotic hypertrophic chondrocytes,
eventually undergoing cell death and leaving amatrix that is con-
verted to bone by invading osteoblasts.
SRY-box-containing gene 9 (Sox9) is a key regulator of ver-
tebrate endochondral skeletal development (Akiyama and Le-
febvre, 2011). Sox9 is initially expressed in mesenchymal
condensations that differentiate into both chondrocytes and os-
teoblasts; early expression is essential for further development
of both cartilage and bone (Akiyama et al., 2002; Akiyama
et al., 2005; Bi et al., 1999). Subsequently, Sox9 expression re-
solves exclusively to chondrocytes; here, Sox9 activity is essen-
tial for the chondrogenic program (Akiyama et al., 2002; Bi et al.,
1999). In this, Sox9 is expressed at the highest levels in mitotic
and early pre-hypertrophic chondrocytes; Sox9 is downregu-
lated as chondrocytes undergo hypertrophic expansion and in
joint-forming regions and joint-associated articular cartilage
(Akiyama et al., 2002; Dy et al., 2012; Wright et al., 1995). Recent
studies have extended Sox9 action from chondrocyte specifica-
tion and early chondrocyte differentiation to the initiation of
chondrocyte hypertrophy (Dy et al., 2012). In summary, Sox9
functions at multiple stages of the cartilage program from
mesenchymal condensation to chondrocyte hypertrophy. The
importance of Sox9 levels to normal development is exemplified
by the fact that haploinsufficiency for Sox9 is lethal in both
mouse and man (Bi et al., 2001; Schafer et al., 1996) and causes
campomelic dysplasia (Foster et al., 1994; Wagner et al., 1994).
Several cis-regulatory enhancer elements associated with
direct, Sox9-dependent regulation have been identified by
random and bioinformatically driven analysis of non-coding re-
gions flanking Sox9 (Mead et al., 2013), Ctgf (connective tissue
growth factor) (Huang et al., 2010), and seven genes encoding
cartilage matrix proteins: Col2a1 (Bell et al., 1997; Lefebvre
et al., 1996; Leung et al., 1998; Zhou et al., 1998),Col9a1 (Genzer
and Bridgewater, 2007; Zhang et al., 2003), Col10a1 (Dy et al.,
2012), Col11a2 (Bridgewater et al., 1998; Bridgewater et al.,
2003; Liu et al., 2000), Col27a1 (Jenkins et al., 2005), Hapln1
(Kou and Ikegawa, 2004),Matn1 (Nagy et al., 2011; RentsendorjCell Reports 12, 229–243, July 14, 2015 ª2015 The Authors 229
Figure 1. Peak Statistics and Annotation of Sox9 ChIP-Seq Data Sets Obtained from Rib Chondrocytes
(A) Distribution of Sox9 peaks relative to predicted RefSeq genes in comparison with the representation of different regions within the mouse genome. Color-
coded distance windows are shown in the same clockwise order as in the pie chart.
(B) Distribution of Sox9 peaks relative to TSSs analyzed by the GREAT GO tools. The y axis represents the percentage of peaks in each distance category; peak
counting is indicated on each bar.et al., 2005), and Acan (Han and Lefebvre, 2008; Hu et al., 2012).
However, as there has been no systematic study of Sox9 ac-
tions, Sox9’s broad regulatory functions in cartilage develop-
ment are not well understood.
To this end, we performed a detailed analysis of Sox9 binding,
chromatin organization, and transcriptional programs within
mammalian chondrocytes isolated directly from the neonatal
mouse rib. In addition, Sox9 programs were compared between
rib and nasal chondrocytes to understand Sox9 actions in chon-
drocytes arising from the distinct cell lineages. Our studies
demonstrate different modes of Sox9 engagement at cartilage-
specific gene targets compared with expressed non-cartilage-
specific genes.
RESULTS
Identification of Sox9 Class I Targets
Rib chondrocytes were manually dissected from post-natal day
1 (P1) mice to include proliferative and prehypertrophic zones
and to exclude mature hypertrophic regions (Figures S1A–S1C;
Supplemental Experimental Procedures). Chondrocytes were
subjected to chromatin immunoprecipitation with a variety of an-
tibodies (Table S1), followed by high-throughput sequencing
(ChIP-seq); the key features of each ChIP-seq dataset are sum-
marized in Table S2.
For Sox9 rib ChIP-seq, 27,656 raw peaks met the peak calling
criterion. The first clear feature of Sox9 ChIP-seq peaks was a
striking enrichment around the transcriptional start site (TSS);
approximately 24.6% (6,794/27,656) of all peaks lie +/- 500
base pairs (bp) around the TSSeven though this region represents
only 0.001% of the genome (McLean et al., 2010) (Figure 1A). In
addition, a large fraction of Sox9 bound regions laid at a consider-
able distance from the TSS; about 50%of all peaksmapped to an
interval between ±50 and 500 kb from the TSS (Figure 1B).
We first examined the characteristics of the TSS-associated
Sox9 dataset within the ±500 bp window around the TSS, here-
after referred to as class I peaks (sheet 1 of Table S3). The peak230 Cell Reports 12, 229–243, July 14, 2015 ª2015 The Authorsquality scores for class I peaks ranked lower than non-TSS-
associated Sox9 regions (Figure 2A): few class I peaks were
mapped within the top 2,000 peaks, while many were found
within the lowest ranked 2,000 peak regions (Figures 2B and
2C). These data suggest either a generally weaker direct binding
interaction or an indirect mode of interaction close to the TSS.
Consistent with the latter argument, Sox9 motifs were not en-
riched in TSS proximal peak regions, whereas enrichment was
observed in Sox9-associated regions more distant from the pro-
moter (Table S4; Figure 2D).
We analyzed gene expression within the same region of the rib
by microarray analysis and compared these data with predicted
class I peak regions. The Sox9 ChIP-seq signal intensity around
the TSSs was highly correlated with the expression level of the
associated genes and with the binding of RNA polymerase II
(Pol II) and p300, an activating component of the transcriptional
complex (Figure 2E); RNA polymerase II and p300 showed a
similar level of co-enrichment (Figures S2A–S2C). To understand
the biological importance of this peak set, we performed a
GREAT Gene Ontology (GREAT GO) analysis (McLean et al.,
2010). Although some chondrogenesis-related genes were pre-
sent in the nearest genes to class I peaks (sheet 1 of Table S3),
class I targets fell within terms related to general cellular pro-
cesses, not chondrocyte-specific activities (Figure 2F). A com-
parison of MGI mouse expression data does show a significant
correlation with rib gene expression (Figure 2F).
In summary, for class I targets, Sox9associatedaround theTSS
of what comprises a large set of genes controlling general cellular
functions not specific to chondrocytes. The level of Sox9 binding
reflects the levels of core transcriptional complex engagement
and, with this, the level of expression of the associated gene.
Identification of Sox9 Class II Targets
Next, we examined the features of the remaining class II peaks
(20,862 regions; sheet 2 of Table S3). Class II peaks showed a
highly enriched recovery of Sox9 motifs, even among the most
distant peaks sets relative to the TSS (Figure 3A), indicative of
Figure 2. TSS-Associated Class I Sox9 ChIP-Seq Peaks
(A) Correlation of frequencies and peak calling scores at class I Sox9 peaks. The x axis represents consecutive bins of high (left) to low (right) peakswith 900 peaks
per bin. The y axis plots the frequency of class I Sox9 peaks within each of the binned peak sets.
(B andC)Mapping of top 2,000 ranked and bottom 2,000 ranked Sox9 peaks in relation to the nearest TSS. The x axis represents distance from the peak center to
the nearest TSS, and the y axis represents the frequency of Sox9 peak enrichment.
(D) Sox dimeric motif frequency in Sox9 peaks around the TSS. Sox9 peaks around TSSs (±3.5 kb from TSSs) were grouped into bins of 1 kb, and the frequencies
of Sox dimeric motifs per peak per kb were plotted.
(E) Signal intensity plots of ChIP-seq data for Sox9, p300, and RNA Pol II in promoter regions (±2 kb from TSSs) compared to input and rabbit (rb) immunoglobulin
G (IgG) controls in relation to expressions of their associated genes. Class I Sox9 peaks were ordered according to the expression level of the nearest associated
gene (highest expression level at top). ChIP-seq signals for RNA Pol II and p300 were mapped to the corresponding Sox9 peak regions.
(F) GREAT GO analysis of class I Sox9 peaks.direct Sox9 binding, and a high conservation score across ver-
tebrate species near the peak center, consistent with an ex-
pected conservation of the cis-regulatory genome (Figure 3B).
A clear association of class II regions with enhancer signatures
was evident; Sox9-bound regions showed an H3K4me2high/
H3K4me3low enhancer signature (He et al., 2010), a strong asso-
ciation of p300 andRNApolymerase II, consistent with active en-
hancers (Heintzman et al., 2007; Kim et al., 2010; Visel et al.,
2009) and peaks of H3K27 acetylation (H3K27Ac) flanking
Sox9, indicative of open chromatin (Heintzman et al., 2007;
Rada-Iglesias et al., 2011; Zentner et al., 2011) (Figures 3C and
3D). In striking contrast to the class I dataset, GREAT GO
showed a highly significant recovery of expected terms for a
Sox9-regulated skeletal program (Figure 3E).We observed substantial Sox9 ChIP-seq signal at 7 of 9 carti-
lage enhancers, which have been identified through rigorous
transgenic analysis, though the one site in Acan was below the
statistical cutoff of the stringent peak calling process (Table
S5). In contrast, we observed Sox9 binding at only 1 of 4 regula-
tory elements associated with Sox9 regulation in testis cells
(Table S5). Figures 3F and 3G show screenshots of ChIP-seq
data around two essential cartilage matrix protein encoding
genes, Acan and Col2a1.
At a higher order level, a marked clustering of Sox9 binding
was evident around key chondrocyte genes expressed at high
levels in chondrocytes (Figure S2D). This is supported by further
analysis using the algorithm to detect so-called super-enhancers
(Whyte et al., 2013). Among 13,648 adjusted rib chondrocyteCell Reports 12, 229–243, July 14, 2015 ª2015 The Authors 231
(legend on next page)
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enhancers in this analysis, we identified 502 super-enhancer
groupings around 422 genes. Expression correlation analysis
showed that the expression levels of super-enhancer-associ-
ated genes were significantly higher than those of typical
enhancer-associated genes (p < 2.2 3 1016) (Figures 3H and
3I; sheets 3 and 4 in Table S3), suggesting that multiple cooper-
ative Sox9-bound enhancersmay have evolved to ensure appro-
priate expression of chondrocyte genes.
Identification of Putative Target Genes for Sox9
We connected class II Sox9 binding events to the nearest genes
and intersected this dataset with microarray-generated gene ex-
pression profiles of comparable chondrocytes. Class II peak-
associated genes were positively expressed in chondrocytes
relative to mouse embryo fibroblasts (MEFs). Further, summing
multiple sites of engagement around a putative target, it is clear
that expression levels of that target increase with increasing
levels of Sox9 engagement (Figure 4A).
We utilized a distance-weighted regulatory potential analysis
tool, S-score (Tang et al., 2011) (Supplemental Experimental
Procedures), to predict the direct target genes for Sox9. The
analysis extracted 735 genes with high confidence (Figure 4B;
sheet 5 in Table S3), including all known Sox9 chondrocyte
target genes mentioned in the Introduction. David GO analysis
on this gene list showed that skeletal system development and
cartilage-related terms were highly enriched (Figure 4C).
Together, the data are consistent with a central role of Sox9 in
the activation of chondrocyte targets. Furthermore, the sum of
Sox9 engagement around a gene rather than Sox9 binding at
any individual site provides the strongest prediction of gene
expression levels (Figures S3A and S3B).
De Novo Motif Analysis of Sox9 Peaks
Sox9 has been shown to activate transcription of chondrocyte-
specific genes through its binding to the inverted repeat of a
quite variable Sox recognition sequence, and that dimerization
is required for activation (Bernard et al., 2003; Bridgewater
et al., 2003; Mead et al., 2013; Sock et al., 2003). We performedFigure 3. Engagement of the Class II Sox9 ChIP-Seq Peaks in Chondro
(A) Sox9motif enrichment in the indicatedwindows from the nearest associated TS
the genome. Blue, percentage of peaks carrying at least one Sox dimeric motif in
control regions.
(B)Conservation of class II Sox9peak regions at±1kb frompeak centers analyzedb
(C) Peak intensity plots of ChIP-seq reads for Sox9, histone modification marks,
samples). Normalized read signals from each ChIP-seq were plotted on a 4-kb w
according to their peak ranking (highest ranking at top). ChIP-seq signals for H3K2
peak regions.
(D) Normalized mean signal intensity for the following ChIP-seq reads: H3K27Ac
H3K27Me3 (black), and H3K36Me3 (brown) centered on class II Sox9 peaks. The
Background signal intensities were determined from complementary position-m
(E) GO biological processes, mouse phenotypes, and MGI expression annotatio
(F and G) CisGenome browser views of Sox9 peaks and associated chromatin and
input control values and a conservation index. Asterisks indicate enhancer regio
validated enhancers in our study that have not been previously reported in the li
(H) Super-enhancer predictions from class II Sox9 ChIP-seq data sets. Adjusted
super-enhancers relative to typical enhancers. The top three super-enhancer tar
(I) Comparison of relative expression of genes associated with Sox9-bound supe
enhancer group.
See also Table S3.de novo motif analysis for class II Sox9 peak regions using two
algorithms, CisGenome (Ji et al., 2008) and MEME-ChIP (Bailey
et al., 2009). The primary motifs recovered were similar to a pre-
viously predicted Sox-dimeric motif, a pair of the Sox consensus
sequences (A/T)(A/T)CAA(A/T)G oriented head to head and
separated by four nucleotides (Bridgewater et al., 2003; Sock
et al., 2003) (Figures 4D and S3C). As expected for direct binding
of Sox9 at class II targets, this dimeric motif is highly enriched at
the predicted center of Sox9 ChIP-seq peaks (Figure 4E). A Sox-
monomer motif was also recovered, though it exhibited a lower
enrichment score and was only weakly centered on Sox9 peaks
(Figures 4F, 4G, and S3C). Thus, the Sox monomer motif does
not likely represent the preferred primary site for Sox9 engage-
ment in chondrocytes. We also recovered significant enrichment
of motifs predicting engagement of AP-1, Nfat, Fox, Runx, and
Hox transcription factor families, consistent with the integration
of multiple regulatory inputs through Sox9-directed enhancer
modules (Figure S3C).
In Vivo Enhancer Activity of Sox9 Peak Regions and
In Vitro Verification of Recovered Motifs
To verify Sox9-regulated enhancers from our data, we selected
a set of predicted enhancers around likely Sox9-target genes,
analyzing enhancer activity in vivo in a zebrafish enhancer
detection (ZED) system (Bessa et al., 2009). Given strong verte-
brate conservation of enhancer modules, we expected that
many would likely operate outside of the mice, in a system bet-
ter suited for large-scale transgenic approaches. Fourteen of
17 tested regions showed chondrocyte-specific reporter gene
expression (Figure 5A; Table S6). While some enhancers were
active as a single copy, others required multimerization to
reveal enhancer activity. Most enhancers were not active in
all chondrocytes but displayed mosaic activity in individual
skeletal elements. Increasing the number of copies of an
individual element increased both the likelihood of enhancer
activity and the level of reporter gene expression, and
decreased mosaicism within the observed expression pattern
(Figure S4A).cyte Development
S relative to position-matched random control regions that are calculated from
the Sox9 peaks; red, percentage of regions carrying Sox dimeric motifs in the
yphastcons in comparisonwithposition-matchedcontrol regions in thegenome.
components of transcriptional machinery, and ChIP controls (input and rb-IgG
indow centered on the Sox9 peak center. Class II Sox9 peaks were ordered
7Ac, H3K4Me2, RNA Pol II, and p300 were mapped to the corresponding Sox9
(red), H3K4Me2 (purple), RNA Pol II (green), p300 (blue), H3K4Me3 (yellow),
y axis represents normalized read counts per bp per peak per 10 million reads.
atched control data.
ns of class II Sox9 peaks analyzed by GREAT GO tools.
p300 and polymerase binding around Acan (Aggrecan) andCol2a1, as well as
ns verified in previous studies (see also Table S6). Boxes highlight functionally
terature.
enhancer ranking and signal intensity were plotted to show the distribution of
get genes are highlighted. See also Table S3.
r-enhancers and typical enhancers. Box plots show gene expression in each
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Figure 4. Prediction of Sox9 Direct Targets
and De Novo Motif Recovery in Sox9 ChIP-
Seq Peaks
(A) Correlation of Sox9 peak signal with expression
of the nearest gene. Sox9 ChIP-seq signal for all
nearby peaks around each RefSeq gene was
compared to the expression levels of the relevant
gene in mouse chondrocytes and embryonic
mouse fibroblasts.
(B) Intersection of Sox9 peak reads and gene
expression levels using S-score analysis. Red,
FDR % 1%; blue, 1% < FDR % 5%; green, 5% <
FDR% 10%; black, FDR > 10%.
(C) DAVID GO analysis for putative Sox9-target
genes predicted by the S-score analysis from
FDR1% to FDR10%. Top five enriched GO terms
are shown.
(D‒G) Enrichment of Sox dimeric motifs (D and E)
and monomer motifs (F and G) recovered de
novo from Sox9 peak regions. Motif logos of the
recovered Sox motifs, which display nucleotide
frequencies (scaled relative to the information
content) at each position, are shown in (D) and (F);
the enrichment level of the Sox motifs mapped to
class II Sox9 peaks is shown in (E) and (G), where
the x and y axis represent the distance from
mapped motifs to the peak center and the fre-
quency of mapped motifs, respectively.
See also Figure S3.To explore Sox9 interactions in more depth, we focused on
an enhancer in the intron of the cartilage matrix-encoding
gene, Col9a1. Sox9 binding was associated with an evolu-
tionary-conserved motif predicted to bind Sox9 dimers within
the identified chondrocyte enhancer element (Figures 5A and
5B). Enhancer-driven chondrocyte-specific gene expression
(Figure 5C, WT) was lost on mutation of the Sox9 site (Fig-
ure 5C, MT). Interestingly, when the endogenous motif was
substituted with the optimum consensus predicted from the
analysis of the entire Sox9 class II dataset, we observed stron-
ger, less mosaic chondrocyte-specific reporter activity (Fig-
ure 5C, OP).
Direct Sox9 interaction with target DNA was examined by an
electrophoresis mobility shift assay (EMSA) on the predicted234 Cell Reports 12, 229–243, July 14, 2015 ª2015 The AuthorsSox dimeric motif for the wild-type
Col9a1 enhancer (WT; Figure 5D) and
one substituting the optimized Sox9 motif
from whole data analysis motif recovery
(OP; Figure 5D). Sox9 bound to both se-
quences; however, binding was markedly
stronger with the optimized Sox9 target
sequence (Figure 5D). As expected,
enhancer binding was dependent on the
HMG-box of Sox9 (Figure 5D). Mutations
in either half-site abolished Sox9 binding
(MT1 and MT2 in Figure 5D). Further, a
mutated Sox9 oligomer failed to compete
with Sox9 binding to the wild-type Sox9
motif (MT; Figure 5E). As expected, the
wild-type motif competed effectively butonly at a high (5-fold) molar excess (WT; Figure 5E). In contrast,
the optimal Sox9 site containing an oligonucleotide competed
effectively at equimolar levels, leading to the loss of most Sox9
binding (OP; Figure 5E).
To determine whether other endogenous Sox9 sites showed
sub-optimal binding relative to the recovered optimum Sox9
motif, we examined Sox9 binding to oligonucleotides incorpo-
rating ten additional predicted endogenous Sox9 binding motifs
and assayed each by EMSA. All ten probes were bound by
Sox9 protein with different levels of binding ability in the EMSA
assay (Figure S4B). All were competed as effectively, or more
effectively, by a 3-fold molar excess of optimal oligonucleotide
compared with oligonucleotides for each wild-type binding site
(Figure S4C).
Together, these data make a strong case for a direct mode of
Sox9 engagement through a dimeric binding motif. Further, the
data suggest that regulation may have favored weaker binding
regions than those predicted from optimal nucleotide posi-
tioning, and the reiteration of multiple, weaker cis-regulatory
modules to maximize output. Consistent with this view, a statis-
tical analysis of the occurrence of two optimal half-sites
(ACAAAG, 298 in 2,474 Sox motifs) predicts 34 optimal motifs
in this dataset, while the observed number is 13 (binomial p value
43 105), and none of these are associated with any likely chon-
drocyte target gene.
Functional Validation of Class I and Class II Engagement
We sought functional roles for class I and class II engagements
through two approaches: (1) examining gene expression
changes of targets upon Sox9 manipulation and (2) intersecting
human SNP data with our dataset.
Regarding the first approach, we ectopically expressed SOX9
in human dermal fibroblasts (hDFs) with an adenoviral vector;
hDFs are reported to acquire chondrocytic phenotypes upon
the introduction of SOX9 (Ikeda et al., 2004). We confirmed no
endogenous SOX9-activity in hDFs by comparing activation of
a 48-bp COL2A1 intron 1 enhancer reporter construct (Kan
et al., 2009) in hDFs with two Sox9+ chondrogenic cell lines (Fig-
ure 6A). Next, we infected hDFs with Sox9-containing virus and
performed RNA sequencing (RNA-seq) 2 days post-infection. A
box plot analysis of expression changes revealed that SOX9
overexpression induced both class I and class II targets (class
I targets, p < 2.2 3 1016; class II targets, p < 2.2 3 1016),
though as expected class II targets showed much larger expres-
sion changes, compared to class I targets (p = 3.43 1016), upon
SOX9 overexpression (Figure 6B). Furthermore, the top 200
highly expressed genes within hDFs displayed a significant
elevation in mRNA levels when SOX9 overexpression was
compared with a control (p = 1.73 105; Figure 6C). GO analysis
revealed that skeletal system development-related terms were
the most significantly enriched in gene sets displaying a 2-fold
or greater increase onSOX9 overexpression (p = 7.23 106; Fig-
ure 6D; sheet 3 in Table S7). In contrast to the above gene sets
comprising 235 genes (fold change rank 1 to 235), the next set
of 235 genes (fold change rank 236 to 470), a low responder
gene sets to SOX9 input, showed little association with skel-
eton-related terms, though ossification-related terms were en-
riched with a low p value (p = 0.048; Figure 6D; sheet 4 in Table
S7). In summary, Sox9 is likely to upregulate a subset of class II
chondrocyte targets in hDFs. Further, Sox9 can broadly elevate
transcript levels for non-chondrocyte genes, consistent with a
general interaction with basal transcriptional components.
To examine the relationship of Sox9 binding with 73million hu-
man SNPs in the NCBI SNP database, we mapped 523,295
SNPs to the mouse genome (mm9), and 100 SNPs were then
matched to homologous mouse Sox9 binding sites in rib chon-
drocytes (sheet 6 in Table S3). We analyzed the closest genes
to the SNPs overlappingwith Sox9 binding sites, and eight genes
(Nfatc1,Ucma,Col9a3, Itga5,Grasp,Col2a1,Glt25d2, andMia1)
were identified from the list of Sox9 putative targets identified by
the S-score analysis of class II targets. This set of SNPsmay be a
useful focus for future exploration in human disease.Comparison of Sox9 Targets and Gene Expression
between Mesodermal- and Neural Crest-Derived
Chondrocytes
To investigate whether Sox9 regulatory networks are similar be-
tween chondrocytes derived from neural crest and mesoderm,
we performed expression profiling and Sox9 ChIP-seq on carti-
lage of E18.5 neural crest-derived nasal septum. Nasal chondro-
cytes at this time are proliferative and Sox9+, Runx2 (Figures
S5A and S5B).
We observed a strong correlation in gene expression between
rib and nasal chondrocytes (Figure 7A). Sox9-bound class II re-
gions recovered from rib chondrocytes were largely bound by
Sox9 in nasal chondrocytes and vice versa (Figure 7B). The ma-
jor differences reflect differences in the weakest component of
the dataset (Figure 7B; intensity plots); the higher ranking Sox9
peaks in the rib chondrocyte data show a higher relative associ-
ation with the top peaks in nasal chondrocytes than in the entire
Sox9 class II peak set (Figure S5C). GREAT GO showed that
skeletal-related terms were highly enriched in nasal chondro-
cytes (Figure S5D). S-score analysis predicted a similar set of
Sox9-target genes to those identified in rib chondrocytes (Fig-
ure S5E; sheet 7 in Table S3), and skeletal development-related
terms are significantly enriched in the target gene set (Fig-
ure S5F). These findings suggest that when Sox9 is activated
in distinct skeletal lineages, Sox9 engages a similar set of target
genes through a highly similar set of cis-regulatory modules.
Interestingly, despite the high correlation among predicted
Sox9-regulated enhancers, some differences are observed.
We found a small number of peaks with differential signal inten-
sities for Sox9 ChIP-seq between these two populations. To
distinguish the biological significance of regions that had signif-
icantly higher Sox9 peak intensity in one population compared to
the other, we performed GREAT GO analysis on such peak
regions identified by peak intensity MA plots (Figure 7C).
Remarkably, when nasal chondrocytes were compared to rib
chondrocytes, Sox9 peak regions that had significantly higher
peak intensity (log2 [nasal/rib] > 2; –log10 p > 10) associated
with disease terms, reflecting abnormal palate and craniofacial
development (Figure 7D; blue; sheet 8 in Table S3). Conversely,
regions with higher Sox9 binding intensity in rib than in nasal
chondrocytes (log2[rib/nasal] > 2, –log10 p > 10) were associated
with genes whose mutation caused abnormal skeletal or carti-
lage development (Figure 7D, red; sheet 9 in Table S3). For
example, among genes associated with each term in Figure 7D
(sheet 10 in Table S3), the Eya1 gene showed a higher expres-
sion level and stronger Sox9 association in nasal chondrocytes,
whereas Hoxc8 expression and Sox9 association in flanking
regions were higher in rib chondrocytes (Figure 7E; sheet 11 in
Table S3). In summary, general Sox9 binding profiles and identi-
fied Sox9 targets are similar between rib and nasal chondro-
cytes, though variation in the levels of Sox9 binding and a small
number of qualitative differences may play a significant role in
regulatory outcomes within distinct chondrocyte populations.
DISCUSSION
Whereas a significant body of information has accrued on epige-
netic control of mammalian gene activity from the systematicCell Reports 12, 229–243, July 14, 2015 ª2015 The Authors 235
Figure 5. Validation of Enhancer Activities of Class II Sox9 ChIP-Seq Peak Regions In Vivo and In Vitro
(A) Enhancer activity testing for regions predicted by Sox9 ChIP-seq analysis utilizing the ZED assay. Alcian blue and Alizarin red staining of a 5-day-old zebrafish
embryo pharyngeal skeleton is shown in the top left. The boxed area in the panel indicates ceratohyal cartilage used to determine in-vivo-enhancer activities. In
(legend continued on next page)
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Figure 6. Induction of Class I and Class II
Targets upon Ectopic SOX9 Expression in
Human Dermal Fibroblasts
(A) Luciferase reporter assay using the luciferase
reporter construct driven by four copies of the
48-bp COL2A1 intron 1 enhancer in human dermal
fibroblasts (hDFs), SW1353, and ATDC5 cells.
RLU, relative light units of experimental and con-
trol reporter vector. Data are means ± SD of trip-
licate experiments.
(B) Comparison of expression changes of class I
and class II targets upon SOX9 overexpression
in hDFs. Box plots show log2 fold changes of
gene expression in the Ad-SOX9-infected group
compared to the Ad-EGFP-infected one.
(C) SOX9 overexpression-induced expression
changes for highly expressed genes in hDFs
deduced fromRNA-seqanalysis. The top200highly
expressed genes in the Ad-EGFP-infected hDFs
were compared between Ad-EGFP and Ad-SOX9-
infected groups. Box plot shows log2 fold changes
of gene expression in the Ad-SOX9-infected group
compared to the Ad-EGFP-infected group.
(D) David GO analysis of the gene set displaying
a 2-fold or greater increase on SOX9 overex-
pression (upper, top 235 genes in the ranking of
Ad-SOX9/Ad-EGFP fold change) and the next
set of 235 genes (lower, rank 236–470 in the
ranking). Top five enriched GO terms are shown
with associated p values.
See also Table S7.study of some well-studied cell types in culture, much less is
known about the relevant cell types in vivo (Birney et al., 2007;
Maher, 2012; Rosenbloom et al., 2010). The mammalian skel-
eton shows a relatively simple, spatially defined differentiation
program in which cell-lineage and genetic studies have estab-
lished cellular and regulatory hierarchies. Chondrocytes and os-
teoblasts arise frommultiple lineages in which a small number ofsome instances, three tandem copies (33) of the enhancer sequence were assayed. Note that the one test
region by our stringent peak calling process, although substantial Sox9 ChIP-seq signal was observed. The nu
peak in that region.
(B) Sox9ChIP-seq signal atCol9a1 gene region. The strong Sox9 peak between exon 29 and 30 ofCol9a1 (chr
analysis in (C).
(C) The effect of twomutations in Sox9motif (MT) or the replacement of endogenous Sox9motif with predicted
of the Col9a1 enhancer. Control lines carried the reporter construct but no test enhancer sequence.
(D) Validation of Sox9 binding to Sox9 motif in Col9a1 enhancer tested in (A) and (C). EMSA was performed
mutated (MT, MT1, and MT2; Supplemental Experimental Procedures), and optimal (OP) Sox dimeric motif. F
deleted Sox9 protein (Sox9dHMG) were examined.
(E) EMSA competition experiment using unlabeledMT,WT, andOP oligos with biotin-labeledWTprobe used i
of unlabeled competitor compared to the labeled WT probe.
Cell Reports 12, 229–transcriptional regulators play a predomi-
nant role in specifying skeletal cell types
(Akiyama et al., 2002; Bi et al., 1999; Dy
et al., 2012; Komori et al., 1997). In par-
ticular, Sox9 has emerged as a key regu-
lator of chondrogenic programs (Akiyama
et al., 2002; Bi et al., 1999; Dy et al., 2012)
and Runx2 and Sp7/Osx critical determi-nants of osteoblast development (Komori et al., 1997; Naka-
shima et al., 2002). The skeletal system and these cell-type-spe-
cific regulatory factors are attractive targets for developing a
deep understanding of regulatory interactions shaping the
mammalian body plan.
Our studies provide many important insights into the Sox9-
directed process of chondrogenesis. The analysis of class I peaksregion for Acan was not identified as a Sox9 peak
mbers (#) indicate the ranking of the Sox9 ChIP-seq
1: 24237068-24237799) was subjected to enhancer
optimized Sox9motif (OP) on the enhancer activity
using labeled probes carrying endogenous (WT),
ull-length Sox9 protein (Sox9FL) and HMG domain-
n (D). Numbers indicate the relativemolarity amount
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Figure 7. Comparison of Gene Expression Profile and Sox9 Binding Regions between Rib and Nasal Chondrocytes
(A) Correlation of gene expression profile between rib and nasal chondrocytes. Different dots represent individual genes. The x and y axis show log2 expression
level of each gene in rib chondrocytes and nasal chondrocytes, respectively.
(B) Comparison of Sox9 peaks between rib and nasal chondrocytes. Venn diagram for Sox9 peak intersection between rib and nasal chondrocytes (upper) and
intensity plots of Sox9ChIP-seq signal in nasal and rib chondrocytes (lower) are shown. Bottom, rib and nasal Sox9 peaks are plotted on a 4-kbwindow from peak
(legend continued on next page)
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shows broad, non-specific engagement of Sox9 at promoter re-
gions within chondrocytes that is likely mediated through pro-
tein-protein interactions with the basal transcription apparatus.
Ectopic expression studies suggest that Sox9 engagement may
elevate overall expression levels. The analysis of Sox9 at non-pro-
moter-associated class II peaks indicates direct DNA binding
through dimeric Sox9 recognition within evolutionarily conserved
enhancer elements. These enhancers cluster around highly ex-
pressed cartilage-related genes, multiple enhancers displaying
active chromatin signatures extending for many 10’s to 100’s of
kilobases from the TSS of the target gene. In vitro analysis of
recovered Sox9 motifs and in-vivo-enhancer organization argues
for a mode of regulation favoring the use of multiple enhancers,
each with a sub-optimal Sox9 binding ability that forms super-
enhancer-like groupings, likely underpinning the high levels of
gene expression observed for the many chondrocyte matrix-en-
coding genes. Interestingly, Sox9 utilizes a qualitatively similar
enhancer set, regardless of chondrocyte origin, though where
there are key genes that distinguish cranial and axial chondro-
cytes, notably Hox genes in the latter, novel patterns of Sox9
engagement are observed in the chondrocyte lineages.
These data provide a comprehensive, genome-scale assess-
ment of Sox9’s action within the nucleus of the normal chon-
drocyte. A limited analysis of Sox9 engagement around the
promoter regions of a selected sub-set of targets has been re-
ported from the study of a rat chondrosarcoma line (Oh et al.,
2010). These studies were recently extended by RNA-seq and
Sox9 ChIP-seq and included some analysis of primary chondro-
cytes (Oh et al., 2014). Unfortunately, we were unable to obtain
the primary data underpinning these studies so we have been
unable to corroborate, compare, or incorporate the findings of
these authors into our work.
Distinct Engagement of Sox9 in Chondrocytes
The two classes of Sox9 binding on the genome point to distinct
function of Sox9 in the regulation of gene activity in chondro-
cytes. Class I binding correlates strikingly, both quantitatively
and spatially, with the engagement of p300, RNA polymerase
II, and, presumably, a spectrum of other components linked to
the basal transcriptional apparatus. Further, the absence of the
enrichment of Sox9 bindingmotifs in this dataset suggests an in-
direct mode of engagement with one or more of the above. Sox9
is known to associate with p300; consequently, their interaction
is likely to account for some, and possibly all, of the class I data
(Furumatsu et al., 2005; Tsuda et al., 2003). These data and anal-
ysis of gene expression following ectopic Sox9 expression in fi-
broblasts suggest a model wherein Sox9 engagement with the
basal transcription apparatus generally elevates gene expres-centers according to their ranking (highest ranked at top). Left, a Sox9 ChIP-seq s
chondrocytes.
(C) A log intensity ratios (M-values) versus log intensity averages (A-values) (MA
different p value levels for confidence levels.
(D) GREAT GO analysis on peak regions identified by peak intensity MA plots sh
tensities are higher in nasal chondrocytes than in rib chondrocytes; red bars, en
chondrocytes than in nasal chondrocytes.
(E) CisGenome browser views of Sox9 ChIP-seq peaks around Eya1 (upper) and
Sox9 peak predictions between nasal and rib chondrocyte data sets.sion. As the levels of Sox9 binding correlate with transcriptional
activity rather than cell-type specificity of the target gene, it is
likely that Sox9’s action on class I targets would be most signif-
icant for highly expressed genes, including housekeeping genes,
independent of any particular function within the cell.
Class II binding associates with broad range of skeletal en-
hancers; the major cartilage matrix-producing genes are promi-
nent targets of the enhancer network. Among this group, we
confirmed Sox9 engagement in most established enhancers
previously linked to Sox9’s regulation of early chondrocyte dif-
ferentiation (Akiyama et al., 2002; Akiyama and Lefebvre, 2011;
Bell et al., 1997) and Sox9’s auto-regulation (Mead et al.,
2013); Sox9 appears as a major target of its own regulation in
our data with discrete binding sites extending for 100’s of kilo-
bases. Two other Sox factors, Sox5 and Sox6, act downstream
of Sox9 (Akiyama et al., 2002) and are also predicted to be direct
targets of Sox9 regulation in the current data.
More contentious is Sox9’s function in maturation of hypertro-
phic chondrocytes. Initial studies based on mouse genetics and
in vitro studies suggested Sox9 inhibits the hypertrophic pro-
gram (Akiyama et al., 2002; Ikeda et al., 2004). Further, Sox9 is
reported to repress transcription of Col10a1, a key gene in the
production of a collagen type restricted to post-mitotic and hy-
pertrophic chondrocyte fates. Here, repression was reported
to map to a Sox motif upstream of the Col10a1 gene (Leung
et al., 2011). However, in contrast to these findings, recent
studies disrupting Sox9 within the growth plate suggest Sox9
promotes hypertrophy, acting cooperatively with Mef2c, a mas-
ter regulator of hypertrophy, to promote transcription of Col10a1
(Dy et al., 2012). We observe a weak Sox9 peak adjacent to the
region identified upstream of Col10a1, but no Sox9 binding to
the regions aroundMef2c. Our ChIP population is predominantly
comprised of mitotic chondrocytes; the prehypertrophic zone is
a small fraction; and hypertrophic chondrocytes are absent.
Clearly, Sox9 protein levels remain elevated within Col10a1-ex-
pressing hypertrophic chondrocytes, so Sox9 may play a
continuing role in maturing chondrocytes. Thus, given potential
heterogeneity of our ChIP population, future ChIP-seq studies
that can overcome the current barrier to extensive dissection
of primary cell types, and the requirement for substantial
amounts of nuclear material to generate comparable robust
data to that presented here, will help to clarify Sox9’s action in
hypertrophic chondrocyte development.
Maintenance of Expression of Key Chondrocyte Genes
through Sox9 Engagement
Sox9 acts predominantly as a homodimer in chondrocytes
(Bridgewater et al., 2003; Coustry et al., 2010; Genzer andignal obtained from rib chondrocytes. Right,a Sox9 ChIP-seq signal from nasal
) plot of rib and nasal chondrocyte Sox9 ChIP-seq peaks. Colors represent
own in (C). Blue bars, enrichment of terms in regions in which Sox9 peak in-
richment of terms in regions in which Sox9 peak intensities were higher in rib
Hoxc8 (lower) in nasal and rib chondrocytes. Asterisks highlight differences in
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Bridgewater, 2007; Jenkins et al., 2005). Our findings lend strong
support to Sox9 dimers as the key regulatory input into chondro-
cyte cis-regulatory modules, which is consistent with the identi-
fication of mutations that disrupt the dimerization capability of
Sox9 in patients with campomelic dysplasia (Bernard et al.,
2003; Sock et al., 2003). Biochemical and statistical analysis of
Sox9 motifs indicates that enhancers favor lower affinity Sox9
sites compared with the highly symmetric homodimer motif
that represents the motif preference from the entire Sox9-bound
enhancer dataset. The reason for this is not clear, but lower affin-
ity interactions may favor cooperative engagement at regulatory
regions. As an example, Sox5 and Sox6, members of the distinct
SoxD sub-family are known to act downstream of Sox9 in chon-
drocyte regulation. While thesemembers can dimerize with each
other, they do not dimerize with Sox9, but engage with Sox9 in
the cooperative regulation of cartilage enhancers for Col2a1
and Acan (Han and Lefebvre, 2008; Lefebvre, 2010; Lefebvre
et al., 1998).
In examining the enhancer landscape around target genes,
and the results of enhancer analysis in transgenic studies, our
data collectively suggest that the transcriptional outcome in
terms of the probability of expression and the level of expression
of a given target gene is likely determined through the use of mul-
tiple enhancer elements. Though our transgenic studies are
limited to facial structures in zebrafish, all enhancers have broad,
general cartilage specificity. Thus, at this level of analysis, en-
hancers are likely ‘‘level-determining modules’’ that sum to
give appropriate levels of expression of the skeletal target
gene rather than ‘‘spatial-determining modules,’’ in which each
acts in a unique range of skeletal elements that sum to cover
the entire skeleton.
Tissue Specificity of Sox9 Binding Modes on the
Genome
Sox9 is amaster regulator ofmale sex determination and skeletal
development. Furthermore, Sox9 action is critical in different
aspects of lung, hair, kidney, ear, hair, and gut development
(reviewed in Lefebvre et al., 2007). How are these specific out-
comes realized? A study of Sox9 interactions in male sex deter-
mination focused on ChIP-chip analysis of promoter regions
(Bhandari et al., 2012). However, on the basis of data here, this
will likely have selected for class I interactions and, consistent
with this conclusion motif recovery, did not provide compelling
evidence for a Sox9 binding motif. In a comparative analysis of
the limited set of cis-regulatory modules engaged by Sox9 in
the testis, including Sox9-itself (Sekido and Lovell-Badge,
2008), miR202 (Wainwright et al., 2013), and Amh (Arango
et al., 1999; De Santa Barbara et al., 1998), none of these en-
hancers were bound by Sox9 in chondrocytes.
Interestingly, reporter constructs comprising five copies of
optimized Sox9 dimer motifs show no chondrocyte activity in
the zebrafish assay. This may reflect accessibility of the reporter
construct if, for example, specific histone modification of an
enhancer is required to enable accessibility of Sox9 (Zhou
et al., 2011). Indeed, the testis enhancers linked to Sox9’s testis
regulatory program did not display poised or active histone
marks (H3K4me2 or H3K27acetyation, respectively) in chondro-
cytes (data not shown). Sox9 binding may also be insufficient for240 Cell Reports 12, 229–243, July 14, 2015 ª2015 The Authorschondrocyte expression (data not shown). Cooperative partner-
ships between Sox9 and Sox5/6 discussed earlier may be one
important factor in determining a specific regulatory outcome
(Han and Lefebvre, 2008; Lefebvre, 2010; Lefebvre et al.,
1998). Cooperative interaction with non-Sox family members is
also suggested by our study. Motifs for AP-1, NFAT, Fox,
Runx, and Hox transcription factor families were all significantly
enriched in the Sox9 ChIP-seq datasets. Given that several of
these families have been implicated in formation and mainte-
nance of cartilage (Behrens et al., 2003; Gross et al., 2012; Kar-
reth et al., 2004; Kimura et al., 2010; Nifuji et al., 2001; Rodova
et al., 2011; Wang et al., 2009; Yoshida et al., 2004; Yueh
et al., 1998), their actions may modulate Sox9 engagement
and cooperate with Sox9 to regulate enhancer activity. The iden-
tification and validation of the core Sox9 network provides a reg-
ulatory framework for extending our understanding of the tran-
scriptional mechanisms at play in mammalian skeletogenesis.
EXPERIMENTAL PROCEDURES
ChIP-Seq
Rib chondrocytes isolated from newborn mice were immediately subjected to
chromatin preparation and ChIP as previously described (Odom et al., 2004;
Vokes et al., 2007). ChIP-seq libraries were constructed using a ChIP-seq
DNA Sample Prep Kit (IP-102-1001; Illumina). Sequencing was performed
on Genome Analyzer II (Illumina). Animal experiment procedures were
approved by the Institutional Animal Care and Use Committees of each
institution.
Expression Profiling
RNA was isolated from rib or nasal chondrocytes using TRIZOL reagent
(15596-026; Life Technologies) andRNeasyMini Kit (74104; QIAGEN) in accor-
dance with manufacturers’ instruction. Microarray analysis was performed on
GeneChip mouse Gene 1.0 ST array (901169; Affymetrix). RNA-seq analysis
was performed on the Illumina platform with Nextseq 500.
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